Interestingly, the reduction in the synthesis of the enzymes involved in SREBP-1-mediated cholesterol biosynthesis in PC-3 prostate cancer cells suggests that the inhibition of this pathway, due to the Cladosporol–PPARγ complex action, also impedes the de novo intratumoral biosynthesis of androgens. This evidence concerns the gene PPARG and prostate cancer.